176 related articles for article (PubMed ID: 28608578)
1. Cantharidin inhibits competitively heme-Fe(III) binding to the FA1 site of human serum albumin.
Polticelli F; Leboffe L; Tortosa V; Trezza V; Fanali G; Fasano M; Ascenzi P
J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28608578
[TBL] [Abstract][Full Text] [Related]
2. Imatinib binding to human serum albumin modulates heme association and reactivity.
Di Muzio E; Polticelli F; Trezza V; Fanali G; Fasano M; Ascenzi P
Arch Biochem Biophys; 2014 Oct; 560():100-12. PubMed ID: 25057771
[TBL] [Abstract][Full Text] [Related]
3. Binding of direct oral anticoagulants to the FA1 site of human serum albumin.
De Simone G; Pasquadibisceglie A; di Masi A; Buzzelli V; Trezza V; Macari G; Polticelli F; Ascenzi P
J Mol Recognit; 2021 Mar; 34(3):e2877. PubMed ID: 33034105
[TBL] [Abstract][Full Text] [Related]
4. All-trans-retinoic acid and retinol binding to the FA1 site of human serum albumin competitively inhibits heme-Fe(III) association.
Di Muzio E; Polticelli F; di Masi A; Fanali G; Fasano M; Ascenzi P
Arch Biochem Biophys; 2016 Jan; 590():56-63. PubMed ID: 26518175
[TBL] [Abstract][Full Text] [Related]
5. Warfarin inhibits allosterically the reductive nitrosylation of ferric human serum heme-albumin.
Ascenzi P; Bocedi A; Gioia M; Fanali G; Fasano M; Coletta M
J Inorg Biochem; 2017 Dec; 177():63-75. PubMed ID: 28926756
[TBL] [Abstract][Full Text] [Related]
6. Fipronil recognition by the FA1 site of human serum albumin.
Ascenzi P; Leboffe L; Toti D; Polticelli F; Trezza V
J Mol Recognit; 2018 Aug; 31(8):e2713. PubMed ID: 29656610
[TBL] [Abstract][Full Text] [Related]
7. Neonicotinoid trapping by the FA1 site of human serum albumin.
Leboffe L; di Masi A; Trezza V; Pasquadibisceglie A; Macari G; Polticelli F; Ascenzi P
IUBMB Life; 2020 Apr; 72(4):716-723. PubMed ID: 31614076
[TBL] [Abstract][Full Text] [Related]
8. Binding behavior of trelagliptin and human serum albumin: Molecular docking, dynamical simulation, and multi-spectroscopy.
Gan R; Zhao L; Sun Q; Tang P; Zhang S; Yang H; He J; Li H
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Sep; 202():187-195. PubMed ID: 29787915
[TBL] [Abstract][Full Text] [Related]
9. Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin.
Yamasaki K; Hyodo S; Taguchi K; Nishi K; Yamaotsu N; Hirono S; Chuang VTG; Seo H; Maruyama T; Otagiri M
PLoS One; 2017; 12(6):e0180404. PubMed ID: 28662200
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal allosteric modulation of carbon monoxide and warfarin binding to ferrous human serum heme-albumin.
Bocedi A; De Sanctis G; Ciaccio C; Tundo GR; Di Masi A; Fanali G; Nicoletti FP; Fasano M; Smulevich G; Ascenzi P; Coletta M
PLoS One; 2013; 8(3):e58842. PubMed ID: 23555601
[TBL] [Abstract][Full Text] [Related]
11. Modulation of heme and myristate binding to human serum albumin by anti-HIV drugs. An optical and NMR spectroscopic study.
Fanali G; Bocedi A; Ascenzi P; Fasano M
FEBS J; 2007 Sep; 274(17):4491-502. PubMed ID: 17725715
[TBL] [Abstract][Full Text] [Related]
12. Physiological changes in the albumin-bound non-esterified free fatty acids critically influence heme/bilirubin binding properties of the protein: A comparative, in vitro, spectroscopic study using the endogenous biomolecules.
Amoorahim M; Ashrafi-Kooshk MR; Esmaeili S; Shahlaei M; Moradi S; Khodarahmi R
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jul; 235():118298. PubMed ID: 32294588
[TBL] [Abstract][Full Text] [Related]
13. Drugs modulate allosterically heme-Fe-recognition by human serum albumin and heme-fe-mediated reactivity.
di Masi A; Leboffe L; Trezza V; Fanali G; Coletta M; Fasano M; Ascenzi P
Curr Pharm Des; 2015; 21(14):1837-47. PubMed ID: 25732555
[TBL] [Abstract][Full Text] [Related]
14. Novel combinations of experimental and computational analysis tested on the binding of metalloprotoporphyrins to albumin.
Hu J; Hernandez Soraiz E; Johnson CN; Demeler B; Brancaleon L
Int J Biol Macromol; 2019 Aug; 134():445-457. PubMed ID: 31078597
[TBL] [Abstract][Full Text] [Related]
15. Molecular interaction of 2,4-diacetylphloroglucinol (DAPG) with human serum albumin (HSA): The spectroscopic, calorimetric and computational investigation.
T PL; Mondal M; Ramadas K; Natarajan S
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Aug; 183():90-102. PubMed ID: 28441541
[TBL] [Abstract][Full Text] [Related]
16. Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin. Optical and NMR spectroscopy characterization.
Fanali G; Fesce R; Agrati C; Ascenzi P; Fasano M
FEBS J; 2005 Sep; 272(18):4672-83. PubMed ID: 16156788
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulation as a tool for assessment of drug binding property of human serum albumin.
Narwal M; Kumar D; Mukherjee TK; Bhattacharyya R; Banerjee D
Mol Biol Rep; 2018 Dec; 45(6):1647-1652. PubMed ID: 30121821
[TBL] [Abstract][Full Text] [Related]
18. Insights into the key interactions between human protein phosphatase 5 and cantharidin using molecular dynamics and site-directed mutagenesis bioassays.
Liu JY; Chen XE; Zhang YL
Sci Rep; 2015 Jul; 5():12359. PubMed ID: 26190207
[TBL] [Abstract][Full Text] [Related]
19. Binding of erucic acid with human serum albumin using a spectroscopic and molecular docking study.
Rabbani G; Baig MH; Jan AT; Ju Lee E; Khan MV; Zaman M; Farouk AE; Khan RH; Choi I
Int J Biol Macromol; 2017 Dec; 105(Pt 3):1572-1580. PubMed ID: 28414112
[TBL] [Abstract][Full Text] [Related]
20. Reductive nitrosylation of ferric human serum heme-albumin.
Ascenzi P; Cao Y; di Masi A; Gullotta F; De Sanctis G; Fanali G; Fasano M; Coletta M
FEBS J; 2010 Jun; 277(11):2474-85. PubMed ID: 20456498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
